Cargando…

The Complexities in Genotyping of Congenital Adrenal Hyperplasia: 21-Hydroxylase Deficiency

The deficiency of 21-hydroxylase due to CYP21A2 pathogenic variants is a rather frequent disease with serious consequences, going from a real mortality risk to infertility and to milder symptoms, nevertheless important for affecting the patients' self-esteem. In the most severe cases life-threa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pignatelli, Duarte, Carvalho, Berta L., Palmeiro, Aida, Barros, Alberto, Guerreiro, Susana G., Macut, Djuro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6620563/ https://www.ncbi.nlm.nih.gov/pubmed/31333583 http://dx.doi.org/10.3389/fendo.2019.00432

Ejemplares similares

Corrigendum: The Complexities in Genotyping of Congenital Adrenal Hyperplasia: 21-Hydroxylase Deficiency
por: Pignatelli, Duarte, et al.
Publicado: (2020)

Metabolic Perspectives for Non-classical Congenital Adrenal Hyperplasia With Relation to the Classical Form of the Disease
por: Macut, Djuro, et al.
Publicado: (2019)

Editorial: Congenital Adrenal Hyperplasia, Unresolved Issues and Implications on Clinical Management
por: Livadas, Sarantis, et al.
Publicado: (2020)

Quality of Life in Men With Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Verhees, Myrthe J. M., et al.
Publicado: (2021)

Characteristics of In2G Variant in Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Kocova, Mirjana, et al.
Publicado: (2022)

Long-Term Health Outcomes of Korean Adults With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Lim, Seung Gyun, et al.
Publicado: (2021)

Treatment and Outcome of Congenital Adrenal Hyperplasia: 21-Hydroxylase Deficiency
por: Lee, Peter A., et al.
Publicado: (2010)

Genetic and clinical characteristics including occurrence of testicular adrenal rest tumors in Slovak and Slovenian patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
por: Saho, Robert, et al.
Publicado: (2023)

Genotype-Phenotype Correlation in Patients with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency in Cuba
por: Espinosa Reyes, Tania Mayvel, et al.
Publicado: (2021)

Pitfalls in molecular diagnosis of 21-hydroxylase deficiency in congenital adrenal hyperplasia
por: Kolahdouz, Mahsa, et al.
Publicado: (2015)

Genotype-phenotype correlations in children and adolescents with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency
por: Dörr, Helmuth-Günther, et al.
Publicado: (2020)

SUN-LB11 What Is the Value of Clinical Suspicion in Neonatal Screening for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency (CAH 21OHD)?
por: Fernández, María Sanz, et al.
Publicado: (2020)

Adrenocortical tumor in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
por: Dung, Vu Chi, et al.
Publicado: (2015)

Birth Size in Neonates with Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
por: Dörr, Helmuth G., et al.
Publicado: (2019)

Sexuality in Males With Congenital Adrenal Hyperplasia Resulting From 21-Hydroxylase Deficiency
por: Gehrmann, Katharina, et al.
Publicado: (2019)

Molecular diagnosis of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
por: Espinosa Reyes, Tania Mayvel, et al.
Publicado: (2020)

THU207 11-oxygenated Androgens Are Strongly Associated With Treatment Quality In Children With Congenital Adrenal Hyperplasia Due To 21-Hydroxylase Deficiency
por: Abawi, Ozair, et al.
Publicado: (2023)

SUN-071 Prenatal and Post-Natal Influence of Androgens in the Psychosexual Development in Individuals with 21-hydroxylase Congenital Adrenal Hyperplasia
por: Batista, Rafael Loch, et al.
Publicado: (2020)

THU187 Genotype-Phenotype Correlation, Clinical Presentation And Feminizing Surgery In Children With Congenital Adrenal Hyperplasia Due To 21-Hydroxylase Deficiency: A Nationwide Multi-Center Study
por: Lind-Holst, Marie, et al.
Publicado: (2023)

Cardiovascular Health in Children and Adolescents With Congenital Adrenal Hyperplasia Due to 21-Hydroxilase Deficiency
por: Improda, Nicola, et al.
Publicado: (2019)

Ectopic Adrenal Tumor in a Patient With Untreated Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Alba, Eva L, et al.
Publicado: (2021)

Concurrence of Meningomyelocele and Salt-Wasting Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
por: Kırmızıbekmez, Heves, et al.
Publicado: (2015)

Mortality in children with classic congenital adrenal hyperplasia and 21-hydroxylase deficiency (CAH) in Germany
por: Dörr, Helmuth G., et al.
Publicado: (2018)

Miscarriages in families with an offspring that have classic congenital adrenal hyperplasia and 21-hydroxylase deficiency
por: Dörr, Helmuth G., et al.
Publicado: (2018)

Update on the Swedish Newborn Screening for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Zetterström, Rolf H., et al.
Publicado: (2020)

Genotype Is Associated to the Degree of Virilization in Patients With Classic Congenital Adrenal Hyperplasia
por: Neocleous, Vassos, et al.
Publicado: (2018)

Genotype-phenotype correlation in patients with 21-hydroxylase deficiency
por: Tang, Peng, et al.
Publicado: (2023)

SAT358 Race And Ethnicity Of Women With 21-hydroxylase Deficient Non-classic Adrenal Hyperplasia (NCAH) Compared With PCOS
por: Pace, Lauren Arielle, et al.
Publicado: (2023)

Long-Term Gynecological Outcomes in Women with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
por: Johannsen, T. H., et al.
Publicado: (2010)

Cardiovascular risk factors in children and adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
por: Subbarayan, Anbezhil, et al.
Publicado: (2014)

A Rare Combination: Congenital Adrenal Hyperplasia Due To 21 Hydroxylase Deficiency and Turner Syndrome
por: Peltek Kendirci, Havva Nur, et al.
Publicado: (2012)

Long term follow up of growth in children with Congenital Adrenal Hyperplasia 21- Hydroxylase deficiency
por: Parikh, Ruchi, et al.
Publicado: (2015)

Recent advances in biochemical and molecular analysis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency
por: Choi, Jin-Ho, et al.
Publicado: (2016)

Crinecerfont Lowers Elevated Hormone Markers in Adults With 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia
por: Auchus, Richard J, et al.
Publicado: (2021)

Growth-Related Characteristics of Patients <18 Years of Age with Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency (21OHD): Real World Evidence from the I-CAH Registry
por: Farrar, Mallory, et al.
Publicado: (2021)

Genotype-phenotype correlation in 27 pediatric patients in congenital adrenal hyperplasia due to 21-hydroxylase deficiency in a single center
por: Yoo, Yangho, et al.
Publicado: (2013)

The prevalence and genotype of 21-hydroxylase deficiency in the Croatian Romani population
por: Dumic, Katja K., et al.
Publicado: (2023)

Assisted Reproduction in Congenital Adrenal Hyperplasia
por: Chatziaggelou, Anastasios, et al.
Publicado: (2019)

Congenital adrenal hyperplasia due to P450 oxidoreductase deficiency
por: Zhang, Jin, et al.
Publicado: (2022)

Genotype-Phenotype Correlation in 153 Adult Patients With Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency: Analysis of the United Kingdom Congenital Adrenal Hyperplasia Adult Study Executive (CaHASE) Cohort
por: Krone, Nils, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_4ao3k9d59t0cubc2291ftcs9l9